Literature DB >> 7112456

Avoidance of reperfusion injury after cardioplegia.

A H Brown, G N Morritt, M Hammo.   

Abstract

Myocardial damage incurred by ischaemia appears during and seems to be accelerated by reperfusion, which restores recoverable cells and disrupts badly damaged ones. Vicious cycles of oedema, calcium accumulation, acidosis, oxygen toxicity, fibrillation and air and platelet emboli contribute to the reperfusion injury. The philosophy of cool low-pressure reperfusion gradually restoring temperature and pressure to normal is here contrasted experimentally with that of immediate normothermic, normotensive perfusion after 90 minutes of ischaemic cool, cardioplegic arrest. The preparation was a canine heart which was treated according to the usual clinical protocol except that one group was reperfused at normal temperature and pressure, and the other group started reperfusion cool and at a low pressure and over the next 10 minutes pressure and temperature were restored to normal. Isovolumic ventricular function studies were done before ischaemia and after recovery and showed statistically significant differences between the groups in favour of the immediate restoration of normal temperature and pressure of perfusion. Contractile velocity and systolic pressure showed very highly significant (p = less than 0.005) differences, wall stress significant (p = less than 0.025) and compliance not significant differences between the groups. Reperfusion with optimal conditions may prevent "vicious cycle" changes in ischaemically damaged but recoverable myocardium. We have shown that a step in this direction is reperfusion with blood at normal temperature and pressure rather than initially at lowered temperature and pressure.

Entities:  

Mesh:

Year:  1982        PMID: 7112456      PMCID: PMC459297          DOI: 10.1136/thx.37.4.275

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  Surgical aspects of regional myocardial blood flow and myocardial pressure.

Authors:  R J Baird; F Dutka; M Okumori; A de la Rocha; M M Goldbach; T J Hill; D C MacGREGOR
Journal:  J Thorac Cardiovasc Surg       Date:  1975-01       Impact factor: 5.209

2.  Prolongation of tension on reoxygenation following myocardial hypoxia: a possible role for mitochondria in muscle relaxation.

Authors:  O H Bing; W W Brooks; J V Messer
Journal:  J Mol Cell Cardiol       Date:  1976-03       Impact factor: 5.000

3.  The calcium paradox: a reaffirmation.

Authors:  T J Ruigrok; F J Burgersdijk; A N Zimmerman
Journal:  Eur J Cardiol       Date:  1975-06

4.  Reperfusion of the ischemic myocardium.

Authors:  D J Hearse
Journal:  J Mol Cell Cardiol       Date:  1977-08       Impact factor: 5.000

5.  Recovery of the heart after normothermic ischemia. Part II: Myocardial function during postischemic reperfusion.

Authors:  J Mulch; J Schaper; M Gottwik; F W Hehrlein
Journal:  Thorac Cardiovasc Surg       Date:  1979-06       Impact factor: 1.827

6.  An experimental evaluation of continuous normothermic, intermittent hypothermic, and intermittent normothermic coronary perfusion.

Authors:  A H Brown; M V Braimbridge; S Darracott; J Chayen; H Kasap
Journal:  Thorax       Date:  1974-01       Impact factor: 9.139

7.  An analysis of the mechanical capabilities of heart muscle during hypoxia.

Authors:  A H Henderson; D L Brutsaert
Journal:  Cardiovasc Res       Date:  1973-11       Impact factor: 10.787

8.  Fine structural and biochemical changes in dog myocardium during autolysis.

Authors:  P B Herdson; J P Kaltenbach; R B Jennings
Journal:  Am J Pathol       Date:  1969-12       Impact factor: 4.307

9.  Studies on myocardial reperfusion injury. I. Favorable modification by adjusting reperfusate pH.

Authors:  D Follette; K Fey; J Livesay; J V Maloney; G D Buckberg
Journal:  Surgery       Date:  1977-07       Impact factor: 3.982

10.  Induced ischemic cardiac arrest. Clinical and experimental results with magnesium-aspartate-procaine solution (Cardioplegin).

Authors:  P Kalmár; N Bleese; V Döring; G Gercken; U Kirsch; W Lierse; H Pokar; M J Polonius; G Rodewald
Journal:  J Cardiovasc Surg (Torino)       Date:  1975 Sep-Oct       Impact factor: 1.888

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.